Eversheds Sutherland advises Edwards Lifesciences on its US$4.2bn sale of Critical Care
06. September 2024
Eversheds Sutherland advises Edwards Lifesciences on its US$4.2bn sale of Critical Care06. September 2024 Eversheds Sutherland has advised Edwards Lifesciences on the US$4.2bn sale of its Critical Care product group to Becton, Dickinson and Company (BD). Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease. The Critical Care product group is an industry leader in advanced patient monitoring with advanced AI algorithms serving millions of patients globally. Ansprechpartner
Lee Harris Partner London, Vereinigtes Königreich Antony Walsh Partner London, Vereinigtes Königreich Barri Mendelsohn Partner London, Vereinigtes Königreich Rachel Cooper Partner Nottingham, Vereinigtes Königreich Edward M. Tompkin-Haag Partner London, Vereinigtes Königreich Kelly Holmes Partner Birmingham, Vereinigtes Königreich Philip Crosbie Partner Leeds, Vereinigtes Königreich Christopher Murray Partner Edinburgh, Vereinigtes Königreich Events und Trainings
virtual Nordic (Denmark, Finland, Norway and Sweden) employment law training 16. Juni 2026 12.45pm - 4pm (BST) Virtual virtual Webinar: Conquering the US Market 23. Juni 2026 17.00-18.00 virtual Introduction to Swiss employment law 23. Juni 2026 2pm - 5pm (GMT) Virtual in-person A leadership conversation for Global GCs 02. September 2026 17:30 - 19:30 MS Wädenswil, Bürkliplatz, Zurich Schiffstation |